Health ❯ Chronic Diseases ❯ Diabetes

Obesity

Hypertension Treatment Options Weight Management Dietary Interventions Dementia Cardiovascular Diseases Sarcopenia Health Outcomes Medication Development Breast Cancer Dietary Changes Risk Factors Impact of Meal Timing Sedentary Lifestyle Kidney Transplants Cardiovascular Risk Lifestyle Factors GLP-1 Agonists Heart Failure Weight Loss Drugs Neurodevelopmental Disorders Treatment Innovations Drug Treatments Smoking Health Risks Medication Effects Dietary Impact Public Health Implications Treatment Protocols Healthcare Access Inflammation GLP-1 Treatments GLP-1 Medications Semaglutide-Based Therapies Cardiometabolic Benefits GLP-1 Receptor Agonists GLP-1 Market Cancer Prevention Cancer Artificial Sweeteners

Semaglutide Extends Lifespan and Slows Ageing in Older Female Mice

An NIH-funded Nature paper shows semaglutide mimics calorie-restriction molecular signatures, improves key functions including memory and blood-sugar control, prompting calls for human trials to assess safety and benefit.

Higher Blood Xylitol Levels Linked to Increased Risk of Heart Attack, Stroke and Death

Lab Study Finds Many Sweeteners Alter Gut Bacteria

Eli Lilly Spends $3.8 Billion to Build Vaccine Business

RSNA Study Links Muscle Mass, Lower Visceral Fat to Younger 'Brain Age'

Semaglutide Curbs Cocaine Use and Relapse-Seeking in Rats, Peer-Reviewed Study Finds

Metformin Linked to Lower Dementia and Mortality Risks in Overweight, Obese Adults

GLP-1 Drugs Linked to Lower Cancer Risk and Mortality in New Study